Biotech company DiaMedica Therapeutics Inc. has raised $16.4 million through its initial public offering.
The Plymouth-based company’s offering priced at the low end of its range, which the company set as between $4 and $5 per share. The company’s stock was down about 9 percent to $3.63 in late-afternoon trading Friday. (It was a pretty negative day on the markets all around, though: The Dow 30, S&P 500, Russell 2000 and NASDAQ were all down 2 percent or more in mid-afternoon trading.)
